Location History:
- Langwiesen, CH (1998 - 2003)
- Schlatt, CH (2008)
Company Filing History:
3 out of 2,359 
1 out of 321 
1 out of 363 
Years Active: 1998-2008
Title: Rainer Naeff: A Pioneer in Pharmaceutical Innovations
Introduction
Rainer Naeff, an accomplished inventor based in Langwiesen, Switzerland, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of five patents, he has focused on innovations that enhance drug efficacy and safety. His work, particularly in the realms of analgesics and drug formulations, has been influential in advancing pharmaceutical science.
Latest Patents
Among his latest inventions, Rainer Naeff has developed a patent for the "Adduct of Topiramate and Tramadol Hydrochloride and Uses Thereof." This innovation outlines processes for the isolation and purification of enantiomerically enriched compositions that include tramadol and topiramate. It also details the subsequent isolation of 1S,2S-tramadol hydrochloride, providing critical advancements in pain management therapies. Another notable patent is the "Erythropoietin Liposomal Dispersion," which showcases his dedication to improving drug delivery systems.
Career Highlights
Throughout his career, Rainer Naeff has held key positions at prestigious companies such as Cilag International GmbH and LTS Lohmann Therapie-Systeme AG. His expertise and innovative mindset have allowed him to work on cutting-edge projects that bridge the gap between research and practical application in the pharmaceutical industry.
Collaborations
Rainer has collaborated with distinguished professionals in the field, including Sandro Delmenico and Achim Berthold. These partnerships have played a crucial role in his creative process, leading to the successful development of various pharmaceutical inventions.
Conclusion
Rainer Naeff's contributions to pharmaceutical innovations demonstrate his dedication to improving medication outcomes for patients. His impressive track record of patents and collaborations underscore his status as a pivotal figure in the world of drug development. As he continues to innovate, the impact of his work will likely resonate throughout the industry for years to come.